Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

General Catalyst stories

Oct 29, 2026

Dren Bio raises $350 million for blood cancer drug ahead of potential 2027 launch

California biotech Dren Bio secured $350 million in funding to advance its lead blood cancer therapy toward a potential market launch by the end of 2027.

Oct 29, 2026·3 sources
00
Oct 20, 2026

Otter.ai raises $320 million from General Catalyst

Meeting note-taking tool Otter.ai raised $320 million from General Catalyst's Customer Value Fund, a non-dilutive financing structure that provides capital without equity dilution.

Oct 20, 2026·2 sources
00
Apr 14, 2026

OpenAI Acquires AI Personal Finance Startup Hiro

OpenAI has acquired Hiro, an AI personal finance startup, signaling the company's intention to build financial planning capabilities into ChatGPT.

Apr 14, 2026·1 source
00

Top claims

  • ▪Dren Bio's prior financing rounds included a $60 million Series A round in October 2020 and a $65 million Series B round in 2022
  • ▪Dren Bio's CD94-targeting monoclonal antibody dibotatug is being evaluated in a Phase 1/2 trial for cytotoxic T cell lymphoma and large granular lymphocytic leukemia, with a primary readout scheduled for December 2026
  • ▪Dren Bio plans to use its $350 million financing to bankroll late-stage development, regulatory, and commercial activities for its lead antibody therapy dibotatug, also known as DR-01

Topics

Biotech startupDrug developmentCancer & OncologyRare diseasesVenture capital fundingClinical trialsAutoimmune disease treatmentsHematology & Blood CancersAI tools & productsAI meeting & workflow assistantsAI startupsPersonal financeAI assistants & chatbots

Related entities

Lightspeed Venture PartnersFinTech